,Set,NGenes,Direction,PValue,FDR
1,WP_ZINC_HOMEOSTASIS,25,Up,3.09385516302022e-05,0.0254933665432866
2,WP_IRON_METABOLISM_DISORDERS,13,Up,0.000789043162462512,0.266947472490998
3,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.00107747259264238,0.266947472490998
4,WP_NUCLEOTIDE_GPCRS,6,Down,0.00172669303620676,0.266947472490998
5,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.00192981730320932,0.266947472490998
6,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Up,0.00232006520233371,0.266947472490998
7,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.00290071886121222,0.266947472490998
8,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.00303747426238059,0.266947472490998
9,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Down,0.00306581915588954,0.266947472490998
10,WP_IRON_METABOLISM_IN_PLACENTA,10,Up,0.00334258157542987,0.266947472490998
11,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,19,Up,0.00361573477819914,0.266947472490998
12,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.00388758455083978,0.266947472490998
13,WP_IDO_METABOLIC_PATHWAY,8,Down,0.00450441763721374,0.285510779466471
14,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.0052968876313684,0.310185801440842
15,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.00587050655120392,0.310185801440842
16,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.00612665899607452,0.310185801440842
17,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.00639946435011446,0.310185801440842
18,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.00799475616631715,0.343877565910775
19,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Up,0.00832153665215813,0.343877565910775
20,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,9,Up,0.00836668789909645,0.343877565910775
21,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.00876387000500762,0.343877565910775
22,WP_MALE_INFERTILITY,70,Up,0.00919118079647072,0.344251498922358
23,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Up,0.00981515705283543,0.3516386700668
24,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.0124465611261309,0.427331931997162
25,WP_FERROPTOSIS,52,Up,0.0184580929091096,0.608378742284252
26,WP_ANGIOGENESIS,15,Up,0.0213603569138388,0.67695900373089
27,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Up,0.0230729623729172,0.682814989458269
28,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Up,0.023527385940543,0.682814989458269
29,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.0242499058460935,0.682814989458269
30,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.0248597690336749,0.682814989458269
31,WP_RETINOL_METABOLISM,6,Down,0.0282353396098467,0.750383036237803
32,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.0291410887859341,0.750383036237803
33,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Up,0.0327491399238032,0.806271216245007
34,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,28,Down,0.0342307442334339,0.806271216245007
35,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.0348311294948001,0.806271216245007
36,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.0362180998061847,0.806271216245007
37,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.0362745591663723,0.806271216245007
38,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.0380032401161897,0.806271216245007
39,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.038160894943635,0.806271216245007
40,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0405352388010041,0.823560797405751
41,WP_ID_SIGNALING,12,Up,0.0456469751864122,0.823560797405751
42,WP_COPPER_HOMEOSTASIS,41,Up,0.0482126685296325,0.823560797405751
43,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.0485347106151522,0.823560797405751
44,WP_ATR_SIGNALING,10,Up,0.0503773992986879,0.823560797405751
45,WP_CCL18_SIGNALING,22,Up,0.0531996863244538,0.823560797405751
46,WP_DNA_DAMAGE_RESPONSE,59,Up,0.0535974064532483,0.823560797405751
47,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.0538233889598401,0.823560797405751
48,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Up,0.0538537437564821,0.823560797405751
49,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.0552265400330817,0.823560797405751
50,WP_GALANIN_RECEPTOR_PATHWAY,11,Up,0.0562161249490413,0.823560797405751
51,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,79,Up,0.056603729407678,0.823560797405751
52,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.0581763715309114,0.823560797405751
53,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.0589841141263585,0.823560797405751
54,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.0594475620558404,0.823560797405751
55,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.0598506211754342,0.823560797405751
56,WP_TP53_NETWORK,16,Up,0.0616464410527824,0.823560797405751
57,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Up,0.0625737729022439,0.823560797405751
58,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.0634263948037073,0.823560797405751
59,WP_THERMOGENESIS,74,Down,0.0636080367371454,0.823560797405751
60,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Down,0.064865794272384,0.823560797405751
61,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.0653811457981918,0.823560797405751
62,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.0659279424731311,0.823560797405751
63,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.0662743518727202,0.823560797405751
64,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Up,0.0668760423048659,0.823560797405751
65,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.0670903718253751,0.823560797405751
66,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.0714116798501888,0.823560797405751
67,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.0714254508085435,0.823560797405751
68,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.0719052970389075,0.823560797405751
69,WP_ENDOCHONDRAL_OSSIFICATION,28,Up,0.0720076161002837,0.823560797405751
70,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,28,Up,0.0720076161002837,0.823560797405751
71,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Up,0.0721137463523398,0.823560797405751
72,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,41,Down,0.0745339870385792,0.823560797405751
73,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,68,Down,0.075760527446421,0.823560797405751
74,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.0765362398389897,0.823560797405751
75,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.0769160204785411,0.823560797405751
76,WP_IL7_SIGNALING,23,Up,0.0774146940039647,0.823560797405751
77,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,53,Up,0.0790227429045934,0.823560797405751
78,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,23,Down,0.0809784547807953,0.823560797405751
79,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Up,0.0814812348957015,0.823560797405751
80,WP_BREAST_CANCER_PATHWAY,88,Up,0.0815284524073902,0.823560797405751
81,WP_NEPHROGENESIS,4,Down,0.0819339003508018,0.823560797405751
82,WP_INTEGRATED_CANCER_PATHWAY,40,Up,0.0826109789817964,0.823560797405751
83,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Up,0.084860279562259,0.823560797405751
84,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.085477420494546,0.823560797405751
85,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.0865378474137182,0.823560797405751
86,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.0886563078692902,0.823560797405751
87,WP_ONECARBON_METABOLISM,22,Up,0.0892692863973419,0.823560797405751
88,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Up,0.0905328941136246,0.823560797405751
89,WP_OSTEOCLAST_SIGNALING,9,Up,0.0936061668581769,0.823560797405751
90,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.0955458633112841,0.823560797405751
91,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.0959483922213222,0.823560797405751
92,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.0962887140459383,0.823560797405751
93,WP_ENERGY_METABOLISM,41,Down,0.0965193366242425,0.823560797405751
94,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.0967882176425867,0.823560797405751
95,WP_COMPLEMENT_SYSTEM,53,Up,0.0988625270703098,0.823560797405751
96,WP_CREATINE_PATHWAY,2,Down,0.0998370693101492,0.823560797405751
97,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Up,0.101496444291748,0.823560797405751
98,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Up,0.103426920111016,0.823560797405751
99,WP_PURINERGIC_SIGNALING,15,Down,0.103725433087224,0.823560797405751
100,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Down,0.104136584973722,0.823560797405751
101,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,0.104396268267009,0.823560797405751
102,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Up,0.10455934619253,0.823560797405751
103,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.105288114435794,0.823560797405751
104,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.106444713706969,0.823560797405751
105,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,0.108129988848622,0.823560797405751
106,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,63,Up,0.109723022904895,0.823560797405751
107,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,88,Up,0.11024335988553,0.823560797405751
108,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.111418554882554,0.823560797405751
109,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.112843584301106,0.823560797405751
110,WP_NEURAL_CREST_DIFFERENTIATION,40,Up,0.112952586132467,0.823560797405751
111,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.113444471680342,0.823560797405751
112,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,50,Down,0.113576644836536,0.823560797405751
113,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.114373678570425,0.823560797405751
114,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.114911804169515,0.823560797405751
115,WP_NRXN1_DELETION_SYNDROME,2,Up,0.116222252516734,0.823560797405751
116,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.117524138917193,0.823560797405751
117,WP_PRION_DISEASE_PATHWAY,28,Up,0.11828426808375,0.823560797405751
118,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.118958658467782,0.823560797405751
119,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.119629513916693,0.823560797405751
120,WP_PROSTAGLANDIN_SIGNALING,24,Down,0.12168794748883,0.823560797405751
121,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.122166644361193,0.823560797405751
122,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.122955043459391,0.823560797405751
123,WP_KREBS_CYCLE_DISORDERS,11,Down,0.126245516357438,0.823560797405751
124,WP_HUNGER_AND_SATIETY,2,Down,0.12698022931867,0.823560797405751
125,WP_COMPLEMENT_ACTIVATION,12,Up,0.127281686906437,0.823560797405751
126,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.129163758318095,0.823560797405751
127,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.12983640168553,0.823560797405751
128,WP_VALPROIC_ACID_PATHWAY,9,Down,0.12992029352041,0.823560797405751
129,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.132480939126335,0.823560797405751
130,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,23,Up,0.132758577986946,0.823560797405751
131,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.134400943504293,0.823560797405751
132,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.134516074676668,0.823560797405751
133,WP_HEME_BIOSYNTHESIS,8,Up,0.134516074676668,0.823560797405751
134,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,55,Up,0.134613389426335,0.823560797405751
135,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Up,0.135165510473544,0.823560797405751
136,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.136115092643658,0.823560797405751
137,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.137726787036444,0.823560797405751
138,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Up,0.13792644422572,0.823560797405751
139,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.142257057582678,0.843308024806666
140,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.143745403541337,0.846044375129015
141,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.14666064999336,0.857080677975383
142,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.148508454329696,0.861767368786403
143,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Up,0.15385925726763,0.874067013418273
144,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.158280525779319,0.874067013418273
145,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.160110303915657,0.874067013418273
146,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.161660249105542,0.874067013418273
147,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.161826034238458,0.874067013418273
148,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Down,0.161959021127127,0.874067013418273
149,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.162610140947929,0.874067013418273
150,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Up,0.163210068890005,0.874067013418273
151,WP_G13_SIGNALING,29,Down,0.166145130460741,0.874067013418273
152,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.167122586168959,0.874067013418273
153,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Up,0.168238666675115,0.874067013418273
154,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.168503237035635,0.874067013418273
155,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.170863447945793,0.874067013418273
156,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,13,Up,0.171121563984374,0.874067013418273
157,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.17160769755401,0.874067013418273
158,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.172585118702232,0.874067013418273
159,WP_FOXP3_IN_COVID19,9,Up,0.172632158252396,0.874067013418273
160,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.17350032808767,0.874067013418273
161,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.174231592203222,0.874067013418273
162,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.175540043093435,0.874067013418273
163,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.177711063228122,0.874067013418273
164,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.178108978650916,0.874067013418273
165,WP_MEVALONATE_PATHWAY,7,Down,0.179151507188746,0.874067013418273
166,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.1800561773622,0.874067013418273
167,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.181192011805292,0.874067013418273
168,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.181855485760784,0.874067013418273
169,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.182028742306536,0.874067013418273
170,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.182629137113995,0.874067013418273
171,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Up,0.185015377646339,0.874067013418273
172,WP_SMALL_LIGAND_GPCRS,7,Up,0.186414118917598,0.874067013418273
173,WP_FOLATE_METABOLISM,37,Up,0.188060981944891,0.874067013418273
174,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Up,0.188277619590068,0.874067013418273
175,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.188739694489784,0.874067013418273
176,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.189695536741642,0.874067013418273
177,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Up,0.19127616459692,0.874067013418273
178,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.191360485847292,0.874067013418273
179,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,14,Up,0.193157018553854,0.874067013418273
180,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.193448832137436,0.874067013418273
181,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.193598147981173,0.874067013418273
182,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.194537187947177,0.874067013418273
183,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.194607678920478,0.874067013418273
184,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.195180012705051,0.874067013418273
185,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.198051895768545,0.87757772699103
186,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.199587955574323,0.87757772699103
187,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.200315244820712,0.87757772699103
188,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.200532908509515,0.87757772699103
189,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.202554639886293,0.87757772699103
190,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.202906442527422,0.87757772699103
191,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.204470205189262,0.87757772699103
192,WP_ERBB_SIGNALING,68,Up,0.204484130561017,0.87757772699103
193,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.206503203297352,0.881650981953462
194,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.209742812070377,0.89086637704119
195,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.211934218200771,0.895557927166337
196,WP_BENZOAPYRENE_METABOLISM,5,Up,0.214992105370925,0.896961539884939
197,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.215536192457406,0.896961539884939
198,WP_CANCER_PATHWAYS,309,Up,0.216599539859518,0.896961539884939
199,WP_IL3_SIGNALING,46,Down,0.216620566064445,0.896961539884939
200,WP_MATRIX_METALLOPROTEINASES,10,Up,0.221975426005829,0.912116224083551
201,WP_PPARALPHA_PATHWAY,15,Up,0.222805490381266,0.912116224083551
202,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.22490776415482,0.912116224083551
203,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.226842109560623,0.912116224083551
204,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.228801993771892,0.912116224083551
205,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.229487558588233,0.912116224083551
206,WP_TRYPTOPHAN_METABOLISM,19,Down,0.231352252767132,0.912116224083551
207,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.232091486426058,0.912116224083551
208,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.23343572901424,0.912116224083551
209,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.234004820682833,0.912116224083551
210,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.234919935400277,0.912116224083551
211,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.237131393584277,0.912116224083551
212,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,36,Up,0.237784930912989,0.912116224083551
213,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.238492288469211,0.912116224083551
214,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.23904828680556,0.912116224083551
215,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.239760610406918,0.912116224083551
216,WP_TRANSLATION_FACTORS,48,Down,0.240751898725279,0.912116224083551
217,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.241636038259885,0.912116224083551
218,WP_NPHP1_DELETION_SYNDROME,10,Down,0.242814724013238,0.912116224083551
219,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.24695165037198,0.912116224083551
220,WP_NAD_METABOLISM,12,Down,0.247152629863569,0.912116224083551
221,WP_RAS_SIGNALING,119,Up,0.247488601876153,0.912116224083551
222,WP_WNT_SIGNALING_WP428,60,Up,0.247617215608841,0.912116224083551
223,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.247893905222321,0.912116224083551
224,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.249737785114128,0.912116224083551
225,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.250408878731128,0.912116224083551
226,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.250951094807646,0.912116224083551
227,WP_RETINOBLASTOMA_GENE_IN_CANCER,72,Up,0.251274736489036,0.912116224083551
228,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.252725157254249,0.913357585866233
229,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,73,Up,0.255600374446583,0.916063575458839
230,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.256321479370721,0.916063575458839
231,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.257455194194365,0.916063575458839
232,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,4,Up,0.258219705684315,0.916063575458839
233,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.259032540147948,0.916063575458839
234,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.261471944939802,0.918960244769239
235,WP_ECTODERM_DIFFERENTIATION,78,Up,0.262082108641713,0.918960244769239
236,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,67,Up,0.267662559910128,0.919845238788177
237,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.268575819994796,0.919845238788177
238,WP_SELENIUM_MICRONUTRIENT_NETWORK,51,Up,0.270334405794358,0.919845238788177
239,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.270493544209036,0.919845238788177
240,WP_NEOVASCULARIZATION_PROCESSES,23,Up,0.271107345853689,0.919845238788177
241,WP_PEPTIDE_GPCRS,16,Up,0.271640081929405,0.919845238788177
242,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.271765744440262,0.919845238788177
243,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.272839584613066,0.919845238788177
244,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.274827479793134,0.919845238788177
245,WP_MELANOMA,55,Up,0.277358055188823,0.919845238788177
246,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.277775024868892,0.919845238788177
247,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.2781783611318,0.919845238788177
248,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.279223683123525,0.919845238788177
249,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Down,0.280296108815036,0.919845238788177
250,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,82,Up,0.28237101492131,0.919845238788177
251,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.282572034718732,0.919845238788177
252,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Up,0.282646797503415,0.919845238788177
253,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.283712561239994,0.919845238788177
254,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.284860872075103,0.919845238788177
255,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.290111428652595,0.919845238788177
256,WP_CILIOPATHIES,128,Down,0.290803199538804,0.919845238788177
257,WP_SERINE_METABOLISM,5,Up,0.293218388951172,0.919845238788177
258,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.294579363993098,0.919845238788177
259,WP_TAMOXIFEN_METABOLISM,2,Up,0.295257172508527,0.919845238788177
260,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Down,0.298487980248988,0.919845238788177
261,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.298840902456019,0.919845238788177
262,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.298869177382213,0.919845238788177
263,WP_VITAMIN_B12_DISORDERS,9,Down,0.300467743953758,0.919845238788177
264,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.300511604355682,0.919845238788177
265,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,57,Up,0.30205186408922,0.919845238788177
266,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,40,Up,0.302556532967767,0.919845238788177
267,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Down,0.30411684419346,0.919845238788177
268,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Up,0.3051452909241,0.919845238788177
269,WP_CHOLESTASIS,9,Up,0.305418128089741,0.919845238788177
270,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,100,Up,0.307195213187,0.919845238788177
271,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.307977501126082,0.919845238788177
272,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.311104128946566,0.919845238788177
273,WP_EICOSANOID_SYNTHESIS,14,Up,0.311314208763427,0.919845238788177
274,WP_CELL_CYCLE,95,Up,0.311698842102953,0.919845238788177
275,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Up,0.313165303306961,0.919845238788177
276,WP_MONOAMINE_GPCRS,4,Down,0.313175672355804,0.919845238788177
277,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.314058794898905,0.919845238788177
278,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.314278598244788,0.919845238788177
279,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Up,0.314817549643333,0.919845238788177
280,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Up,0.315952653535245,0.919845238788177
281,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.319000471390741,0.919845238788177
282,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Up,0.319963185424233,0.919845238788177
283,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.320452991585872,0.919845238788177
284,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.320686223234977,0.919845238788177
285,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.320977204554644,0.919845238788177
286,WP_HEART_DEVELOPMENT,17,Up,0.321140243780956,0.919845238788177
287,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Down,0.321202754065866,0.919845238788177
288,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.321499306760916,0.919845238788177
289,WP_OPIOID_RECEPTOR_PATHWAYS,26,Down,0.32455045211874,0.925361842719175
290,WP_PARKINSONS_DISEASE_PATHWAY,27,Up,0.326481011714809,0.927656391906905
291,WP_SPHINGOLIPID_PATHWAY,21,Down,0.330381399349336,0.935512965855166
292,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.33473594113914,0.938365437062199
293,WP_FRAGILE_X_SYNDROME,84,Down,0.334872970114123,0.938365437062199
294,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.335283810244153,0.938365437062199
295,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.335943936812316,0.938365437062199
296,WP_SPINAL_CORD_INJURY,69,Up,0.337742126385446,0.940201054532458
297,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,0.340031099038509,0.942761896286365
298,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.34231001765078,0.942761896286365
299,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.343130233222584,0.942761896286365
300,WP_ESTROGEN_SIGNALING,21,Up,0.343238554473191,0.942761896286365
301,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.346695556183775,0.945258389455656
302,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.347640400857692,0.945258389455656
303,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.348609155925672,0.945258389455656
304,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.350679051467969,0.945258389455656
305,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.353162038099418,0.945258389455656
306,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,175,Up,0.353555889433296,0.945258389455656
307,WP_ENDOMETRIAL_CANCER,49,Up,0.355800177831294,0.945258389455656
308,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.35843203879702,0.945258389455656
309,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.3613244718297,0.945258389455656
310,WP_JOUBERT_SYNDROME,71,Down,0.36397822363904,0.945258389455656
311,WP_ONCOSTATIN_M_SIGNALING,56,Up,0.364860653993906,0.945258389455656
312,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.367325847371474,0.945258389455656
313,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Up,0.367941331654515,0.945258389455656
314,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.369017636344834,0.945258389455656
315,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.369567433033846,0.945258389455656
316,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,15,Down,0.369596245621606,0.945258389455656
317,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.36976006568543,0.945258389455656
318,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Up,0.36981655820253,0.945258389455656
319,WP_P38_MAPK_SIGNALING,31,Down,0.372368233311244,0.945258389455656
320,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.373485293058887,0.945258389455656
321,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.374612678847265,0.945258389455656
322,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.37486438222795,0.945258389455656
323,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.37511337687679,0.945258389455656
324,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Up,0.37642722907709,0.945258389455656
325,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.376463354107977,0.945258389455656
326,WP_LEPTIN_SIGNALING,69,Down,0.380410390508229,0.945258389455656
327,WP_DOPAMINE_METABOLISM,7,Up,0.381829326557678,0.945258389455656
328,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.382528201629749,0.945258389455656
329,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Down,0.382541834495545,0.945258389455656
330,WP_ARYLAMINE_METABOLISM,1,Up,0.385348288077393,0.945258389455656
331,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.385709024330694,0.945258389455656
332,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.386032754457445,0.945258389455656
333,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.386032754457445,0.945258389455656
334,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.387300756871021,0.945258389455656
335,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.38919566135134,0.945258389455656
336,WP_KLEEFSTRA_SYNDROME,25,Down,0.389858548635138,0.945258389455656
337,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.390543480930829,0.945258389455656
338,WP_HYPERTROPHY_MODEL,13,Down,0.390662418691174,0.945258389455656
339,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.391728238643746,0.945258389455656
340,WP_CYTOSINE_METHYLATION,7,Up,0.391772068742599,0.945258389455656
341,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.392906536802123,0.945258389455656
342,WP_EGFEGFR_SIGNALING,140,Up,0.394236267304752,0.945258389455656
343,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.395804220258561,0.945258389455656
344,WP_TGFB_SMAD_SIGNALING,7,Down,0.39821838667692,0.945258389455656
345,WP_CIRCADIAN_RHYTHM_GENES,121,Up,0.398759274345275,0.945258389455656
346,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.399622713943647,0.945258389455656
347,WP_BURN_WOUND_HEALING,62,Up,0.4006291859281,0.945258389455656
348,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.400850227380676,0.945258389455656
349,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.402061370716528,0.945258389455656
350,WP_INTEGRINMEDIATED_CELL_ADHESION,74,Down,0.403683218613115,0.945258389455656
351,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.405110052415873,0.945258389455656
352,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.406336743180195,0.945258389455656
353,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.406628084976082,0.945258389455656
354,WP_IL1_SIGNALING,53,Down,0.407294403856547,0.945258389455656
355,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Up,0.410232332275116,0.945258389455656
356,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.410495118535847,0.945258389455656
357,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.41479518016676,0.945258389455656
358,WP_PDGF_PATHWAY,36,Down,0.416666668970129,0.945258389455656
359,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Up,0.41753064947658,0.945258389455656
360,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.417809169201946,0.945258389455656
361,WP_NEUROINFLAMMATION,10,Down,0.419670821316888,0.945258389455656
362,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.421824907037115,0.945258389455656
363,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,71,Down,0.422336868962303,0.945258389455656
364,WP_ALSTROM_SYNDROME,27,Up,0.424202898057569,0.945258389455656
365,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.424555175626319,0.945258389455656
366,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.424860450143552,0.945258389455656
367,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Up,0.42487630532801,0.945258389455656
368,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.425253567547238,0.945258389455656
369,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.425396770600289,0.945258389455656
370,WP_BASE_EXCISION_REPAIR,29,Up,0.426233706413044,0.945258389455656
371,WP_VITAMIN_B12_METABOLISM,24,Up,0.426262563834732,0.945258389455656
372,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Up,0.427701842711918,0.945258389455656
373,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Up,0.429991046724913,0.945258389455656
374,WP_PURINE_METABOLISM,10,Up,0.430957036856917,0.945258389455656
375,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Down,0.431552531253219,0.945258389455656
376,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.432515541330954,0.945258389455656
377,WP_SILDENAFIL_TREATMENT,11,Up,0.433155823464929,0.945258389455656
378,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,50,Down,0.435532273311727,0.945258389455656
379,WP_PI3KAKT_SIGNALING,181,Up,0.435900886639178,0.945258389455656
380,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Up,0.439808409578664,0.945258389455656
381,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.44250506836203,0.945258389455656
382,WP_DOPAMINERGIC_NEUROGENESIS,5,Up,0.442805847506205,0.945258389455656
383,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Up,0.444463214219196,0.945258389455656
384,WP_EBOLA_VIRUS_INFECTION_IN_HOST,109,Up,0.444487249263597,0.945258389455656
385,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.445395673593103,0.945258389455656
386,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.446253977012541,0.945258389455656
387,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.446370694006171,0.945258389455656
388,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.446392950684351,0.945258389455656
389,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.447146507914121,0.945258389455656
390,WP_NRF2_PATHWAY,73,Up,0.449498853346851,0.945258389455656
391,WP_SMALL_CELL_LUNG_CANCER,71,Up,0.452354747696705,0.945258389455656
392,WP_BARDETBIEDL_SYNDROME,65,Down,0.453345173342547,0.945258389455656
393,WP_ALLOGRAFT_REJECTION,51,Up,0.455142691126275,0.945258389455656
394,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Up,0.455527021615866,0.945258389455656
395,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Up,0.456045015292366,0.945258389455656
396,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.456349640765543,0.945258389455656
397,WP_RETT_SYNDROME,32,Down,0.457314627460304,0.945258389455656
398,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.457670780072659,0.945258389455656
399,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.458371928404044,0.945258389455656
400,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.45886329585226,0.945258389455656
401,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.461162908310398,0.945904172949588
402,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Up,0.465799673065704,0.945904172949588
403,WP_TNFALPHA_SIGNALING,83,Down,0.468466207584624,0.945904172949588
404,WP_AMINO_ACID_METABOLISM,60,Down,0.4686123499989,0.945904172949588
405,WP_NRF2ARE_REGULATION,21,Up,0.46927946947559,0.945904172949588
406,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,139,Up,0.470680780524504,0.945904172949588
407,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.471453933479112,0.945904172949588
408,WP_GLYCOLYSIS_IN_SENESCENCE,11,Down,0.471872542305651,0.945904172949588
409,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,26,Up,0.472505006211147,0.945904172949588
410,WP_OREXIN_RECEPTOR_PATHWAY,118,Down,0.473204887133593,0.945904172949588
411,WP_OSTEOPONTIN_SIGNALING,12,Up,0.473343521320958,0.945904172949588
412,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Down,0.473819439534819,0.945904172949588
413,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Down,0.474100028432257,0.945904172949588
414,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.475621026175164,0.946646680116752
415,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.478047958788962,0.948937411620576
416,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.479075198099708,0.948937411620576
417,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Up,0.482251370308981,0.950714736619996
418,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.483230182164782,0.950714736619996
419,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.483451409628462,0.950714736619996
420,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.4856008104732,0.950714736619996
421,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.486798734042828,0.950714736619996
422,WP_APOPTOSIS,72,Up,0.488334699982489,0.950714736619996
423,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.490606074108231,0.950714736619996
424,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.493186026907562,0.950714736619996
425,WP_IL6_SIGNALING,39,Up,0.493528174803543,0.950714736619996
426,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.496801498664236,0.950714736619996
427,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Up,0.497211067933695,0.950714736619996
428,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.497548674278313,0.950714736619996
429,WP_CHOLESTEROL_METABOLISM,53,Down,0.498083802017344,0.950714736619996
430,WP_MONOAMINE_TRANSPORT,12,Down,0.49921923175679,0.950714736619996
431,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.49953477953158,0.950714736619996
432,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.499878383921376,0.950714736619996
433,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.5020891233047,0.950714736619996
434,WP_CHEMOKINE_SIGNALING,115,Down,0.502389695888098,0.950714736619996
435,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.507987403714433,0.950714736619996
436,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.508564097653886,0.950714736619996
437,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.512662425143501,0.950714736619996
438,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.513302472513656,0.950714736619996
439,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Up,0.516158540665351,0.950714736619996
440,WP_PYRIMIDINE_METABOLISM,71,Up,0.516729116757071,0.950714736619996
441,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.517028628117343,0.950714736619996
442,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.519126276068213,0.950714736619996
443,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Up,0.520044664298402,0.950714736619996
444,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Up,0.52048921363707,0.950714736619996
445,WP_SLEEP_REGULATION,11,Up,0.521646675816291,0.950714736619996
446,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.522868559344751,0.950714736619996
447,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,64,Up,0.52307850658977,0.950714736619996
448,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.526232021514731,0.950714736619996
449,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.526498948869606,0.950714736619996
450,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Down,0.528333699165636,0.950714736619996
451,WP_MEASLES_VIRUS_INFECTION,101,Down,0.530119786627355,0.950714736619996
452,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.530595229067449,0.950714736619996
453,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.531767469339033,0.950714736619996
454,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.53220273208636,0.950714736619996
455,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.532700050376915,0.950714736619996
456,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.533268010841605,0.950714736619996
457,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.533268010841605,0.950714736619996
458,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.533291946252076,0.950714736619996
459,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,33,Down,0.533628521105028,0.950714736619996
460,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.533691892390113,0.950714736619996
461,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.541691468688962,0.950714736619996
462,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.54241804880107,0.950714736619996
463,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.54317175607897,0.950714736619996
464,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.543612108270084,0.950714736619996
465,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Up,0.544716674526461,0.950714736619996
466,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Up,0.544971817378616,0.950714736619996
467,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.545793328204788,0.950714736619996
468,WP_OSTEOBLAST_SIGNALING,3,Up,0.546134852324387,0.950714736619996
469,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.546380591118664,0.950714736619996
470,WP_MAPK_CASCADE,30,Up,0.549212289582,0.950714736619996
471,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.549806516209037,0.950714736619996
472,WP_CAMKK2_PATHWAY,30,Up,0.552021097118382,0.950714736619996
473,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.553846450087656,0.950714736619996
474,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.553972294277526,0.950714736619996
475,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.554749841567773,0.950714736619996
476,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.555959802893408,0.950714736619996
477,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.556476313903452,0.950714736619996
478,WP_ENDODERM_DIFFERENTIATION,82,Up,0.556613021437166,0.950714736619996
479,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Down,0.558249103426406,0.950714736619996
480,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.558687452459082,0.950714736619996
481,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,92,Down,0.559667982938709,0.950714736619996
482,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.560860240917774,0.950714736619996
483,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.560976759563112,0.950714736619996
484,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Up,0.563975736628206,0.950714736619996
485,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,168,Up,0.565188156678113,0.950714736619996
486,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.566181765457297,0.950714736619996
487,WP_GLYOXYLATE_METABOLISM,5,Down,0.568362372586595,0.950714736619996
488,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.568941801337987,0.950714736619996
489,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.56896686991285,0.950714736619996
490,WP_PANCREATIC_CANCER_SUBTYPES,6,Up,0.569889036277824,0.950714736619996
491,WP_PROTEASOME_DEGRADATION,57,Up,0.570370938406837,0.950714736619996
492,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.570780795260396,0.950714736619996
493,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Up,0.571940566300768,0.950714736619996
494,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,63,Up,0.572027014558795,0.950714736619996
495,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.573045005158318,0.950714736619996
496,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.57333971067805,0.950714736619996
497,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.573428670024439,0.950714736619996
498,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.574697648079399,0.950905345416516
499,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.582184483397993,0.952669112846987
500,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.583341277230784,0.952669112846987
501,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.584950585967031,0.952669112846987
502,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.587135016850472,0.952669112846987
503,WP_PREIMPLANTATION_EMBRYO,21,Up,0.587563906965077,0.952669112846987
504,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.587616030319538,0.952669112846987
505,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,85,Down,0.589038637726575,0.952669112846987
506,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.589445649563933,0.952669112846987
507,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Up,0.589835172206483,0.952669112846987
508,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.59290029320872,0.952669112846987
509,WP_NUCLEAR_RECEPTORS,20,Down,0.594167475516861,0.952669112846987
510,WP_SPINA_BIFIDA,10,Up,0.595979305520977,0.952669112846987
511,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.596319350321943,0.952669112846987
512,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Down,0.596875579925873,0.952669112846987
513,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.597898524870429,0.952669112846987
514,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.600307118662453,0.952669112846987
515,WP_PROLACTIN_SIGNALING,70,Up,0.600406320720652,0.952669112846987
516,WP_NUCLEAR_RECEPTORS_METAPATHWAY,180,Up,0.600621110974946,0.952669112846987
517,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.600744384575181,0.952669112846987
518,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.601444969847289,0.952669112846987
519,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.602046586672847,0.952669112846987
520,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Up,0.602178350702773,0.952669112846987
521,WP_MIRNA_BIOGENESIS,6,Up,0.602440788196048,0.952669112846987
522,WP_BLADDER_CANCER,30,Up,0.603511258381223,0.952669112846987
523,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Up,0.604827676574578,0.952921616629927
524,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.607216049555146,0.95356362103456
525,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.609679896515207,0.95356362103456
526,WP_KIT_RECEPTOR_SIGNALING,52,Up,0.609966334453548,0.95356362103456
527,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.613361962972638,0.95356362103456
528,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.614223805936539,0.95356362103456
529,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.615283481070545,0.95356362103456
530,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.617146673431706,0.95356362103456
531,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Down,0.61720171278947,0.95356362103456
532,WP_KALLMANN_SYNDROME,11,Up,0.618376850875809,0.95356362103456
533,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,36,Up,0.61846932630247,0.95356362103456
534,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.61890448722988,0.95356362103456
535,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.619581762651643,0.95356362103456
536,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.620503417714896,0.95356362103456
537,WP_DRAVET_SYNDROME,14,Up,0.621436486038299,0.95356362103456
538,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.623510935956801,0.954968422357628
539,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.627883269098213,0.958846365872783
540,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.628370191227309,0.958846365872783
541,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.634404421165875,0.963585136273778
542,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.637749924167071,0.963585136273778
543,WP_DNA_MISMATCH_REPAIR,21,Up,0.638458708656592,0.963585136273778
544,WP_NETRINUNC5B_SIGNALING,35,Up,0.638747353042233,0.963585136273778
545,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.639865413729577,0.963585136273778
546,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.640976984140776,0.963585136273778
547,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Up,0.641556463635718,0.963585136273778
548,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.641749998970942,0.963585136273778
549,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Down,0.642000291036777,0.963585136273778
550,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Down,0.645224531336879,0.966663661493797
551,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.646502647425406,0.966820656040897
552,WP_GPCRS_OTHER,15,Up,0.648914423652208,0.96700092916739
553,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.649840792185165,0.96700092916739
554,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.650412152145672,0.96700092916739
555,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.651704262031426,0.96700092916739
556,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.653102178929786,0.96700092916739
557,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.653664463041548,0.96700092916739
558,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.65607755165374,0.967317362799438
559,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.658993679466301,0.967317362799438
560,WP_HIPPO_SIGNALING_REGULATION,45,Down,0.659809698127889,0.967317362799438
561,WP_IL9_SIGNALING,15,Up,0.661490398113288,0.967317362799438
562,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.663298808121028,0.967317362799438
563,WP_MTHFR_DEFICIENCY,18,Up,0.664012581933186,0.967317362799438
564,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.666247337354468,0.967317362799438
565,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.666524756496982,0.967317362799438
566,WP_TAR_SYNDROME,44,Down,0.666937836822661,0.967317362799438
567,WP_VITAMIN_D_RECEPTOR_PATHWAY,87,Up,0.668423019993742,0.967317362799438
568,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.669646860872307,0.967317362799438
569,WP_IL4_SIGNALING,50,Down,0.672258809569547,0.967317362799438
570,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.677241462810896,0.967317362799438
571,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Up,0.67738178423348,0.967317362799438
572,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.677469342994943,0.967317362799438
573,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.678301574996482,0.967317362799438
574,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.678520579391865,0.967317362799438
575,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.681126756911003,0.967317362799438
576,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.68246852156626,0.967317362799438
577,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.683299843912499,0.967317362799438
578,WP_AGERAGE_PATHWAY,55,Up,0.68330488224059,0.967317362799438
579,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Up,0.683468702921649,0.967317362799438
580,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Down,0.68708547193294,0.967317362799438
581,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Up,0.687094902512343,0.967317362799438
582,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Up,0.687825206124407,0.967317362799438
583,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,26,Up,0.687832354534198,0.967317362799438
584,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.689474890234553,0.967317362799438
585,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.689841432059238,0.967317362799438
586,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,24,Up,0.690507635428336,0.967317362799438
587,WP_WNT_SIGNALING_WP363,39,Up,0.692654581205734,0.967317362799438
588,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.693036442854009,0.967317362799438
589,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.694209620171075,0.967317362799438
590,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.695910960804964,0.967317362799438
591,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.695961281680512,0.967317362799438
592,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.696210421361339,0.967317362799438
593,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.697246226422478,0.967317362799438
594,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.698072558268695,0.967317362799438
595,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.698487658817555,0.967317362799438
596,WP_INSULIN_SIGNALING,131,Up,0.699935559573733,0.967696142766369
597,WP_AXON_GUIDANCE,36,Up,0.705708343612508,0.970869350176908
598,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.707559763586186,0.970869350176908
599,WP_MAPK_SIGNALING,164,Up,0.707599209130358,0.970869350176908
600,WP_TGFBETA_RECEPTOR_SIGNALING,35,Up,0.708463094209166,0.970869350176908
601,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.712044462592011,0.970869350176908
602,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.712298790674905,0.970869350176908
603,WP_PRIMARY_OVARIAN_INSUFFICIENCY,89,Up,0.713253154771524,0.970869350176908
604,WP_OVARIAN_INFERTILITY,21,Up,0.714565273175959,0.970869350176908
605,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.715583290560865,0.970869350176908
606,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.716049691724177,0.970869350176908
607,WP_FOXA2_PATHWAY,9,Up,0.716237702443892,0.970869350176908
608,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.716369617606262,0.970869350176908
609,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.719288873994283,0.971095789918616
610,WP_IL5_SIGNALING,37,Down,0.719309726610353,0.971095789918616
611,WP_NOTCH_SIGNALING_WP61,49,Up,0.720945150532202,0.971095789918616
612,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Down,0.72125075659004,0.971095789918616
613,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.723596431173221,0.97266469704198
614,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.726726432177544,0.975281075104718
615,WP_SYNAPTIC_VESICLE_PATHWAY,22,Up,0.72947069626784,0.977372119877561
616,WP_LUNG_FIBROSIS,36,Up,0.734473113786208,0.978943141583636
617,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.737522614308752,0.978943141583636
618,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Down,0.738204181391446,0.978943141583636
619,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.738610307281783,0.978943141583636
620,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.740771985064554,0.978943141583636
621,WP_GPR40_PATHWAY,8,Up,0.741093100398829,0.978943141583636
622,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.741316949223337,0.978943141583636
623,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.742446681298737,0.978943141583636
624,WP_VEGFAVEGFR2_SIGNALING,343,Down,0.744726797971708,0.978943141583636
625,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.747933039738849,0.978943141583636
626,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.748126975212094,0.978943141583636
627,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.748710561600852,0.978943141583636
628,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.749107965054894,0.978943141583636
629,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.749411742980308,0.978943141583636
630,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,40,Up,0.75026890571683,0.978943141583636
631,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.752338291677227,0.978943141583636
632,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.753300019566213,0.978943141583636
633,WP_NONSMALL_CELL_LUNG_CANCER,60,Up,0.754836216108293,0.978943141583636
634,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Up,0.756736874910115,0.978943141583636
635,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.756933985520584,0.978943141583636
636,WP_IL2_SIGNALING,37,Up,0.757649615495898,0.978943141583636
637,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.757672765547861,0.978943141583636
638,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.760176403540934,0.978943141583636
639,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.760488006704878,0.978943141583636
640,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.761281716526997,0.978943141583636
641,WP_ASPIRIN_AND_MIRNAS,8,Up,0.763481734902533,0.978943141583636
642,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.764804807901573,0.978943141583636
643,WP_SEROTONIN_AND_ANXIETY,7,Up,0.768269286739639,0.978943141583636
644,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.769908032846365,0.978943141583636
645,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Up,0.77054239811236,0.978943141583636
646,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.77078284748458,0.978943141583636
647,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.772564888750907,0.978943141583636
648,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.774218567210904,0.978943141583636
649,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Up,0.775287009513219,0.978943141583636
650,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.776388963566415,0.978943141583636
651,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.777288918840067,0.978943141583636
652,WP_IL19_SIGNALING,20,Up,0.77759012845621,0.978943141583636
653,WP_PLEURAL_MESOTHELIOMA,258,Up,0.779948969198354,0.978943141583636
654,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.781426903230134,0.978943141583636
655,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.782734437535281,0.978943141583636
656,WP_BDNFTRKB_SIGNALING,26,Up,0.783405116498298,0.978943141583636
657,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.783686040848735,0.978943141583636
658,WP_HEPATITIS_B_INFECTION,118,Up,0.784156874799764,0.978943141583636
659,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.784731845375553,0.978943141583636
660,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.785718765003374,0.978943141583636
661,WP_ACE_INHIBITOR_PATHWAY,5,Up,0.786045037738078,0.978943141583636
662,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Down,0.786481019087824,0.978943141583636
663,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.790293368645606,0.982204729659094
664,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.793564683265944,0.98231959449935
665,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.793778590200555,0.98231959449935
666,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.79396219652496,0.98231959449935
667,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Up,0.798084911328606,0.98265855005846
668,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.798170607286646,0.98265855005846
669,WP_UROTENSINIIMEDIATED_SIGNALING,49,Up,0.799017022866363,0.98265855005846
670,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Up,0.800014953647394,0.98265855005846
671,WP_TRANSSULFURATION_PATHWAY,8,Down,0.800198892098576,0.98265855005846
672,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Up,0.801468501349672,0.982753043321622
673,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.803045238070502,0.983223292971907
674,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.804994449532866,0.983537855560068
675,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.806494411195775,0.983537855560068
676,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.807376815116603,0.983537855560068
677,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Down,0.810224967807051,0.983537855560068
678,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.8105312867597,0.983537855560068
679,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.811516344341844,0.983537855560068
680,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.811753838280788,0.983537855560068
681,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.81285106751991,0.983537855560068
682,WP_G_PROTEIN_SIGNALING,62,Up,0.823344292992607,0.985161288005863
683,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,128,Up,0.823614030839862,0.985161288005863
684,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Up,0.824195924270437,0.985161288005863
685,WP_KETOGENESIS_AND_KETOLYSIS,6,Down,0.825482064681924,0.985161288005863
686,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.826620882869199,0.985161288005863
687,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.827329955458041,0.985161288005863
688,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.827399591691071,0.985161288005863
689,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.827640274107415,0.985161288005863
690,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.827681011487673,0.985161288005863
691,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.82820151532782,0.985161288005863
692,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.828358211239381,0.985161288005863
693,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.828690447029952,0.985161288005863
694,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,43,Down,0.829735356645715,0.985161288005863
695,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.831504455728539,0.985841253986066
696,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.834465458331314,0.985958142596101
697,WP_ACUTE_VIRAL_MYOCARDITIS,66,Down,0.835490378832115,0.985958142596101
698,WP_NEPHROTIC_SYNDROME,27,Down,0.83579269509376,0.985958142596101
699,WP_VITAMIN_D_METABOLISM,6,Down,0.836823931325322,0.985958142596101
700,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.838559729265589,0.985958142596101
701,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.841102903670696,0.985958142596101
702,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.84167326154732,0.985958142596101
703,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.842189367416867,0.985958142596101
704,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.842372005324824,0.985958142596101
705,WP_GPCRS_CLASS_A_RHODOPSINLIKE,46,Up,0.845880518725731,0.986624659127305
706,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Up,0.846244245365268,0.986624659127305
707,WP_GASTRIC_CANCER_NETWORK_2,26,Up,0.846808427987146,0.986624659127305
708,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.849065809872755,0.986624659127305
709,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.849937991635407,0.986624659127305
710,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Up,0.853122329777459,0.986624659127305
711,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.855425238533423,0.986624659127305
712,WP_GLIOBLASTOMA_SIGNALING,68,Up,0.856029498758766,0.986624659127305
713,WP_KININKALLIKREIN_PATHWAY,2,Up,0.857295803714145,0.986624659127305
714,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Up,0.857645097176146,0.986624659127305
715,WP_HISTONE_MODIFICATIONS,37,Up,0.858176676363627,0.986624659127305
716,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.858632631238974,0.986624659127305
717,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.85888061388397,0.986624659127305
718,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.859704496666754,0.986624659127305
719,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.862279375447033,0.98820334543582
720,WP_IRINOTECAN_PATHWAY,5,Up,0.867846929559962,0.98972865343339
721,WP_IL18_SIGNALING,192,Up,0.868048724926588,0.98972865343339
722,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.868142857692873,0.98972865343339
723,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Up,0.868414825767404,0.98972865343339
724,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Up,0.870509361231816,0.990584561569229
725,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.871570154293314,0.990584561569229
726,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Up,0.874670993597299,0.992551573575819
727,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.876329363855907,0.992551573575819
728,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.877294832626186,0.992551573575819
729,WP_METHYLATION_PATHWAYS,5,Down,0.879405985919521,0.992551573575819
730,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Up,0.880490145897347,0.992551573575819
731,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.881964200516155,0.992551573575819
732,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.882827532326939,0.992551573575819
733,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.883803691606985,0.992551573575819
734,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Up,0.885577677387645,0.992551573575819
735,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.887359272367334,0.992551573575819
736,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Down,0.887499874450515,0.992551573575819
737,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.888648643404252,0.992551573575819
738,WP_NOTCH_SIGNALING_WP268,35,Down,0.888960025848245,0.992551573575819
739,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.894067580618626,0.993394561032709
740,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.894103923583511,0.993394561032709
741,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.897584026785099,0.993394561032709
742,WP_AEROBIC_GLYCOLYSIS,10,Up,0.897880779975564,0.993394561032709
743,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.897880779975564,0.993394561032709
744,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.899216451668831,0.993394561032709
745,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.90131686304039,0.993394561032709
746,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.901788523590984,0.993394561032709
747,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.901788523590984,0.993394561032709
748,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.90226088139974,0.993394561032709
749,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.902976366763955,0.993394561032709
750,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.90492467927113,0.994210580959214
751,WP_IL11_SIGNALING,40,Up,0.906748271801944,0.99488758450706
752,WP_ADIPOGENESIS,86,Down,0.908040378992165,0.994980415278649
753,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.910597341701366,0.995187307685836
754,WP_IL26_SIGNALING,32,Up,0.910843263087952,0.995187307685836
755,WP_FOCAL_ADHESION,122,Down,0.913954196793201,0.995187307685836
756,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.915345495718341,0.995187307685836
757,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.916842694681333,0.995187307685836
758,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.921578304478085,0.995187307685836
759,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.922733259006803,0.995187307685836
760,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.923318356793145,0.995187307685836
761,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.92384346910887,0.995187307685836
762,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.926514485664223,0.995187307685836
763,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Down,0.926859138562789,0.995187307685836
764,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.927589715217271,0.995187307685836
765,WP_PPAR_SIGNALING,39,Up,0.928412420460155,0.995187307685836
766,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.930157522515539,0.995187307685836
767,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Up,0.930453772679307,0.995187307685836
768,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.930940647856742,0.995187307685836
769,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.931974410203678,0.995187307685836
770,WP_ATM_SIGNALING,34,Up,0.932242031640845,0.995187307685836
771,WP_CILIARY_LANDSCAPE,185,Down,0.933546297160949,0.995187307685836
772,WP_GLUTATHIONE_METABOLISM,10,Up,0.933587841124582,0.995187307685836
773,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.934679864550499,0.995187307685836
774,WP_MRNA_PROCESSING,124,Up,0.934799728335967,0.995187307685836
775,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.937658927382611,0.995745471699601
776,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.938651533511602,0.995745471699601
777,WP_GLUCURONIDATION,7,Down,0.938949310085667,0.995745471699601
778,WP_AUTOPHAGY,27,Down,0.943714597085171,0.99640610137118
779,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.94719845178372,0.99640610137118
780,WP_ENDOTHELIN_PATHWAYS,12,Up,0.947263944944178,0.99640610137118
781,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Up,0.948135972392899,0.99640610137118
782,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.94966452794203,0.99640610137118
783,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,43,Down,0.952339777127724,0.99640610137118
784,WP_CORI_CYCLE,11,Down,0.952768301864735,0.99640610137118
785,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.952829225574294,0.99640610137118
786,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.953050137582665,0.99640610137118
787,WP_ALZHEIMERS_DISEASE,184,Down,0.957085986299822,0.99640610137118
788,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Down,0.957085986299822,0.99640610137118
789,WP_HIPPOYAP_SIGNALING,16,Up,0.960540887061908,0.99640610137118
790,WP_MACROPHAGE_MARKERS,8,Up,0.964425054004887,0.99640610137118
791,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.965641621992313,0.99640610137118
792,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Up,0.966146374456357,0.99640610137118
793,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Up,0.966551082690215,0.99640610137118
794,WP_PDGFRBETA_PATHWAY,27,Down,0.966882604101545,0.99640610137118
795,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.968396716470716,0.99640610137118
796,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.968396716470716,0.99640610137118
797,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Up,0.972464566285034,0.99640610137118
798,WP_DNA_REPLICATION,36,Down,0.972509672220134,0.99640610137118
799,WP_STEROID_BIOSYNTHESIS,2,Down,0.972950422504508,0.99640610137118
800,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.973016563205159,0.99640610137118
801,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.975175452802507,0.99640610137118
802,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,7,Down,0.979677765597887,0.99640610137118
803,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Down,0.979947886702468,0.99640610137118
804,WP_REGULATION_OF_ACTIN_CYTOSKELETON,93,Up,0.980180403216869,0.99640610137118
805,WP_B_CELL_RECEPTOR_SIGNALING,86,Up,0.984522762678041,0.99640610137118
806,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.984832255485503,0.99640610137118
807,WP_GASTRIN_SIGNALING,93,Up,0.985042459420884,0.99640610137118
808,WP_RANKLRANK_SIGNALING,47,Up,0.985529910844904,0.99640610137118
809,WP_ESTROGEN_METABOLISM_WP5276,8,Down,0.987893554555959,0.99640610137118
810,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.987922059583265,0.99640610137118
811,WP_BENZENE_METABOLISM,3,Up,0.989352870923862,0.99640610137118
812,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.989757653762789,0.99640610137118
813,WP_CELLULAR_PROTEOSTASIS,6,Up,0.990240702773473,0.99640610137118
814,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.990597242747364,0.99640610137118
815,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,9,Up,0.990703522618356,0.99640610137118
816,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,18,Up,0.991207410220725,0.99640610137118
817,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.991269661778758,0.99640610137118
818,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Up,0.991618338150414,0.99640610137118
819,WP_IL17_SIGNALING,25,Up,0.992007978551581,0.99640610137118
820,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,277,Down,0.992660890304812,0.99640610137118
821,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.992778409254537,0.99640610137118
822,WP_LUNG_PATHOLOGY_OF_COVID19,15,Up,0.996697473702539,0.998445045784814
823,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Down,0.997511691694685,0.998445045784814
824,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.998445045784814,0.998445045784814
